Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Invested Capital: 2024

Historic Return on Invested Capital for Sunshine Biopharma (SBFM) over the last 1 years, with Dec 2024 value amounting to -0.25%.

  • Sunshine Biopharma's Return on Invested Capital was N/A to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year change of. This contributed to the annual value of -0.25% for FY2024, which is N/A change from last year.
  • As of FY2024, Sunshine Biopharma's Return on Invested Capital stood at -0.25%.
  • Sunshine Biopharma's 5-year Return on Invested Capital high stood at -0.25% for FY2024, and its period low was -0.25% during FY2024.
  • Over the past 1 years, Sunshine Biopharma's median Return on Invested Capital value was -0.25% (recorded in 2024), while the average stood at -0.25%.